Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
85.69 (1y: +64%)
Market Cap 30.97 B P/E(ttm) 25.20
Enterprise Value 37.08 B P/B 2.00
TMO- NYSE (USA)
Thermo Fisher Scientific Inc
  • Currently 3.5/5
Business Predictability Rank: 3.5-Star
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$85.69
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry		 vs
history
Cash to Debt 0.12
TMO's Cash to Debt is ranked lower than
89% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. TMO: 0.12 )
TMO' s 10-Year Cash to Debt Range
Min: 0.12   Max: 2.13
Current: 0.12
0.12
2.13
Equity to Asset -0.175
TMO's Equity to Asset is ranked lower than
93% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. TMO: -0.175 )
TMO' s 10-Year Equity to Asset Range
Min: -0.18   Max: 0.28
Current: -0.18
-0.18
0.28
Interest Coverage 6.8
TMO's Interest Coverage is ranked lower than
67% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. TMO: 6.8 )
TMO' s 10-Year Interest Coverage Range
Min: 7   Max: No Debt
Current: 6.8
F-Score: 6
Z-Score: 2.72
M-Score: -2.67
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 11.80
TMO's Operating margin (%) is ranked higher than
64% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. TMO: 11.80 )
TMO' s 10-Year Operating margin (%) Range
Min: 1.6   Max: 11.8
Current: 11.8
1.6
11.8
Net-margin (%) 9.4
TMO's Net-margin (%) is ranked higher than
67% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. TMO: 9.4 )
TMO' s 10-Year Net-margin (%) Range
Min: -7.1   Max: 16.4
Current: 9.4
-7.1
16.4
ROE (%) 7.6
TMO's ROE (%) is ranked higher than
60% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. TMO: 7.6 )
TMO' s 10-Year ROE (%) Range
Min: -8.7   Max: 15.2
Current: 7.6
-8.7
15.2
ROA (%) 4.3
TMO's ROA (%) is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. TMO: 4.3 )
TMO' s 10-Year ROA (%) Range
Min: -3.4   Max: 10.1
Current: 4.3
-3.4
10.1
ROC (Joel Greenblatt) (%) 40.00
TMO's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. TMO: 40.00 )
TMO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.9   Max: 43.8
Current: 40
5.9
43.8
Revenue Growth (%) 9.3
TMO's Revenue Growth (%) is ranked higher than
70% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. TMO: 9.3 )
TMO' s 10-Year Revenue Growth (%) Range
Min: -8.1   Max: 13.7
Current: 9.3
-8.1
13.7
EBITDA Growth (%) 11.6
TMO's EBITDA Growth (%) is ranked higher than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. TMO: 11.6 )
TMO' s 10-Year EBITDA Growth (%) Range
Min: -16   Max: 25.9
Current: 11.6
-16
25.9
EPS Growth (%) 12.4
TMO's EPS Growth (%) is ranked higher than
83% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.15 vs. TMO: 12.4 )
TMO' s 10-Year EPS Growth (%) Range
Min: 0   Max: 24.4
Current: 12.4
0
24.4
» TMO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

TMO Guru Trades in Q2 2012

RS Investment Management 120,300 sh (New)
Jim Simons 1,362,844 sh (New)
David Dreman 265,841 sh (New)
Scott Black 133,250 sh (+150.35%)
Ray Dalio 259,234 sh (+139.44%)
Andreas Halvorsen 2,772,343 sh (+57.22%)
First Pacific Advisors 3,324,500 sh (+41.08%)
Steven Romick 3,190,000 sh (+39%)
Brian Rogers 5,000,000 sh (+17.65%)
Larry Robbins 5,218,547 sh (+12.24%)
John Rogers 1,185,108 sh (+8.1%)
Pioneer Investments 902,422 sh (+7.73%)
John Griffin 5,010,000 sh (+7.51%)
Jeremy Grantham 4,913 sh (unchged)
Jean-Marie Eveillard 200 sh (unchged)
Arnold Van Den Berg 194,929 sh (-0.81%)
Dodge & Cox 121,002 sh (-0.98%)
John Buckingham 85,791 sh (-1.4%)
Robert Olstein 166,000 sh (-4.05%)
Steven Cohen 1,435,269 sh (-14%)
Mario Gabelli 4,000 sh (-14.62%)
Bruce Kovner 4,500 sh (-91.67%)
Paul Tudor Jones 12,000 sh (-96.58%)
» More
Q3 2012

TMO Guru Trades in Q3 2012

Pioneer Investments 1,511,577 sh (+67.5%)
Scott Black 150,633 sh (+13.05%)
First Pacific Advisors 3,664,600 sh (+10.23%)
Steven Romick 3,515,000 sh (+10.19%)
Jeremy Grantham 5,413 sh (+10.18%)
Jean-Marie Eveillard 200 sh (unchged)
Bruce Kovner 4,500 sh (unchged)
Mario Gabelli 4,000 sh (unchged)
John Griffin 5,010,000 sh (unchged)
Brian Rogers 5,000,000 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Dodge & Cox 120,002 sh (-0.83%)
John Buckingham 81,220 sh (-5.33%)
Arnold Van Den Berg 177,804 sh (-8.79%)
John Rogers 1,067,448 sh (-9.93%)
RS Investment Management 106,070 sh (-11.83%)
Larry Robbins 4,025,181 sh (-22.87%)
Robert Olstein 119,000 sh (-28.31%)
Andreas Halvorsen 1,899,646 sh (-31.48%)
David Dreman 172,711 sh (-35.03%)
Steven Cohen 861,718 sh (-39.96%)
Ray Dalio 105,224 sh (-59.41%)
» More
Q4 2012

TMO Guru Trades in Q4 2012

Paul Tudor Jones 5,900 sh (New)
Bruce Kovner 48,800 sh (+984.44%)
Pioneer Investments 1,618,742 sh (+7.09%)
First Pacific Advisors 3,720,600 sh (+1.53%)
Steven Romick 3,565,000 sh (+1.42%)
Jeremy Grantham 5,473 sh (unchged)
Jean-Marie Eveillard 200 sh (unchged)
Mario Gabelli 4,000 sh (unchged)
Brian Rogers 5,000,000 sh (unchged)
John Griffin 5,010,000 sh (unchged)
Andreas Halvorsen Sold Out
John Rogers 1,065,956 sh (-0.14%)
Scott Black 150,253 sh (-0.25%)
John Buckingham 79,320 sh (-2.34%)
Arnold Van Den Berg 171,524 sh (-3.53%)
Dodge & Cox 114,402 sh (-4.67%)
Robert Olstein 98,000 sh (-17.65%)
Larry Robbins 3,201,443 sh (-20.46%)
Ray Dalio 52,824 sh (-49.8%)
David Dreman 47,111 sh (-72.72%)
Steven Cohen 168,958 sh (-80.39%)
RS Investment Management 3,450 sh (-96.75%)
» More
Q1 2013

TMO Guru Trades in Q1 2013

Louis Moore Bacon 150,000 sh (New)
Steve Mandel 2,847,088 sh (New)
Daniel Loeb 1,300,000 sh (New)
Pioneer Investments 1,710,783 sh (+5.69%)
First Pacific Advisors 3,865,800 sh (+3.9%)
Steven Romick 3,695,000 sh (+3.65%)
Paul Tudor Jones 6,100 sh (+3.39%)
John Rogers 1,071,393 sh (+0.51%)
Larry Robbins 3,201,443 sh (unchged)
John Griffin 5,010,000 sh (unchged)
Jean-Marie Eveillard 200 sh (unchged)
Ray Dalio Sold Out
Mario Gabelli Sold Out
Jeremy Grantham Sold Out
RS Investment Management Sold Out
John Buckingham 78,976 sh (-0.43%)
Arnold Van Den Berg 167,262 sh (-2.48%)
Scott Black 138,122 sh (-8.07%)
Dodge & Cox 103,802 sh (-9.27%)
Brian Rogers 4,500,000 sh (-10%)
Steven Cohen 122,642 sh (-27.41%)
David Dreman 32,869 sh (-30.23%)
Robert Olstein 56,000 sh (-42.86%)
Bruce Kovner 4,500 sh (-90.78%)
» More
» Details

Insider Trades

Latest Guru Trades with TMO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Daniel Loeb 2013-03-31 New Buy1.9%$63.78 - $77.7 $ 85.6918%1300000
Steve Mandel 2013-03-31 New Buy1.1%$63.78 - $77.7 $ 85.6918%2847088
Scott Black 2013-03-31 Reduce -8.07%0.11%$63.78 - $77.7 $ 85.6918%138122
Ray Dalio 2013-03-31 Sold Out 0.03%$63.78 - $77.7 $ 85.6918%0
David Dreman 2013-03-31 Reduce -30.23%0.03%$63.78 - $77.7 $ 85.6918%32869
Mario Gabelli 2013-03-31 Sold Out $63.78 - $77.7 $ 85.6918%0
David Dreman 2012-12-31 Reduce -72.72%0.18%$57.61 - $65.28 $ 85.6939%47111
Ray Dalio 2012-12-31 Reduce -49.8%0.04%$57.61 - $65.28 $ 85.6939%52824
Scott Black 2012-09-30 Add 13.05%0.15%$49.78 - $60.61 $ 85.6954%150633
Ray Dalio 2012-09-30 Reduce -59.41%0.12%$49.78 - $60.61 $ 85.6954%105224
David Dreman 2012-09-30 Reduce -35.03%0.11%$49.78 - $60.61 $ 85.6954%172711
Scott Black 2012-06-30 Add 150.35%0.66%$48.89 - $56.48 $ 85.6963%133250
David Dreman 2012-06-30 New Buy0.32%$48.89 - $56.48 $ 85.6963%265841
John Griffin 2012-06-30 Add 7.51%0.27%$48.89 - $56.48 $ 85.6963%5010000
Ray Dalio 2012-06-30 Add 139.44%0.12%$48.89 - $56.48 $ 85.6963%259234
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about Thermo Fisher Scientific Inc

Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE
January 13, 2013
According to GuruFocus Insider Data, the largest CFO sells during the past week were: Thermo Fisher Scientific Inc., Infoblox Inc., Verisk Analytics Inc., Charles River Laboratories International Inc., Ingredion Inc., and Guidewire Software Inc. Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 25.20
TMO's P/E(ttm) is ranked lower than
55% of the 107 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.90 vs. TMO: 25.20 )
TMO' s 10-Year P/E(ttm) Range
Min: 10.29   Max: 2435
Current: 25.2
10.29
2435
P/B 2.00
TMO's P/B is ranked higher than
65% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. TMO: 2.00 )
TMO' s 10-Year P/B Range
Min: 0.86   Max: 2.59
Current: 2
0.86
2.59
P/S 2.47
TMO's P/S is ranked lower than
53% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. TMO: 2.47 )
TMO' s 10-Year P/S Range
Min: 1.2   Max: 3.87
Current: 2.47
1.2
3.87
PFCF 19.00
TMO's PFCF is ranked higher than
71% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.70 vs. TMO: 19.00 )
TMO' s 10-Year PFCF Range
Min: 10.22   Max: 284.57
Current: 19
10.22
284.57
EV-to-EBIT 25
TMO's EV-to-EBIT is ranked lower than
70% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.73 vs. TMO: 25 )
TMO' s 10-Year EV-to-EBIT Range
Min: 11.2   Max: 137.2
Current: 25
11.2
137.2
PEG 2.5
TMO's PEG is ranked lower than
61% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. TMO: 2.5 )
TMO' s 10-Year PEG Range
Min: 0.5   Max: 38.94
Current: 2.5
0.5
38.94
Shiller P/E 30.6
TMO's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: vs. TMO: 30.6 )
TMO' s 10-Year Shiller P/E Range
Min: 17.18   Max: 67.39
Current: 30.6
17.18
67.39

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 0.65
TMO's Dividend Yield is ranked lower than
88% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. TMO: 0.65 )
TMO' s 10-Year Dividend Yield Range
Min: 0.22   Max: 0.86
Current: 0.65
0.22
0.86
Dividend Payout 0.1548
TMO's Dividend Payout is ranked higher than
85% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. TMO: 0.1548 )
TMO' s 10-Year Dividend Payout Range
Min: 0.17   Max: 0.17
Current: 0.15
Yield on cost (5-Year) 0.70
TMO's Yield on cost (5-Year) is ranked lower than
79% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. TMO: 0.70 )
TMO' s 10-Year Yield on cost (5-Year) Range
Min: 0.22   Max: 0.86
Current: 0.7
0.22
0.86
Share Buyback Rate 3.5
TMO's Share Buyback Rate is ranked higher than
78% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. TMO: 3.5 )
TMO' s 10-Year Share Buyback Rate Range
Min: 3.5   Max: -27.5
Current: 3.5

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 15
TMO's Price/Net Current Asset Value is ranked lower than
51% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.00 vs. TMO: 15 )
TMO' s 10-Year Price/Net Current Asset Value Range
Min: 5.8   Max: 15.4
Current: 15
5.8
15.4
Price/DCF (Projected) 1
TMO's Price/DCF (Projected) is ranked higher than
82% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. TMO: 1 )
TMO' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 1.8
Current: 1
0.6
1.8
Price/Median PS Value 1.3
TMO's Price/Median PS Value is ranked lower than
62% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. TMO: 1.3 )
TMO' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.3
Current: 1.3
0.7
1.3
Price/Peter Lynch Fair Value 2.5
TMO's Price/Peter Lynch Fair Value is ranked lower than
78% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. TMO: 2.5 )
TMO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.6   Max: 2.2
Current: 2.5
0.6
2.2
Earnings Yield (Greenblatt) 4.00
TMO's Earnings Yield (Greenblatt) is ranked lower than
70% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. TMO: 4.00 )
TMO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 8.9
Current: 4
0.7
8.9
Forward Rate of Return (Yacktman) 13.37
TMO's Forward Rate of Return (Yacktman) is ranked lower than
51% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.37 vs. TMO: 13.37 )
TMO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -35.2   Max: 37.7
Current: 13.37
-35.2
37.7

Business Description

Thermo Fisher Scientific Inc. is a Delaware corporation and was incorporated in 1956. The Company enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. Markets served include pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. The company's continuing operations fall into three business segments: Analytical Technologies, Specialty Diagnostics, and Laboratory Products and Services. Analytical Technologies segment provides a broad offering of instruments, reagents, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field. These products are used by customers in all four of the company's key end markets: healthcare and diagnostics; pharmaceutical and biotechnology; academic and government; and industrial and applied. Specialty Diagnostics segment provides a wide range of diagnostic test kits, reagents, culture media, instruments and associated products used to increase the speed and accuracy of diagnoses. These products are used by customers in healthcare, clinical, pharmaceutical, industrial and food safety laboratories. Laboratory Products and Services segment provides virtually everything needed for the laboratory, including a combination of self-manufactured and sourced products and an extensive service offering. These products and services are used by customers in pharmaceutical, biotechnology, academic, government and other research and industrial markets, as well as the clinical laboratory. The Company markets and sells its products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors and various catalogs. The Company encounters aggressive and able competition in virtually all of the markets it serves. It is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and other countries.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, COO, ISRG
Traded in other countries:TN8.Germany
» More Articles for TMO

Headlines

Articles On GuruFocus.com
Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE Jan 13 2013 
The 3 Most-Recommended Healthcare Stocks Jan 02 2013 
My Best Healthcare Stock Picks For 2013 | Last Year’s Picks Gained 31.55% Dec 04 2012 
My 5 Favorite Health Care Growth Picks of the Next 5 Years Nov 02 2012 
10 from the Experts for '12’s Second Half Jul 02 2012 
Donaldson's New Projects Will Drive Stock Higher Apr 23 2012 
Could These Science Stocks Provide Big Gains? Mar 11 2012 
Covidien: Great Buy, Great Margins Mar 02 2012 
FPA Crescent Fund Buys Arris Group, Thermo Fisher, Citigroup, Sells Pfizer Inc, eBay, Pharmerica Feb 27 2012 
Stocks that are cheaper than Robert Olstein bought Feb 18 2012 

More From Our Partners
MedTech Industry Stock Update - May 2013 - Zacks Analyst Interviews May 15 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial